- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04950413
Instrument-assisted Soft Tissue Mobilization and Phonophoresis on Trigger Points of Tension Headache
Effect of Instrument-assisted Soft Tissue Mobilization and Phonophoresis on Trigger Points of Tension Headache
General purpose:
It was investigate the effect of IASTM and phonophoresis on Tension Type headache.
Specific Purpose:
- It was investigate the effect of IASTM on headache frequency, PPT, pain intensity, and functional disability on trigger points of tension type headache.
- It was investigate the effect of Lidocaine phonophoresis on headache frequency, PPT, pain intensity and functional disability on trigger points of tension type headache.
- It was investigate the effect of IASTM and Lidocaine phonophoresis on headache frequency, PPT, pain intensity, and functional disability on trigger points of tension type headache.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Phonophoresis is the use of therapeutic ultrasound to increase percutaneous drug absorption Percutaneous administration offers many benefits such as steady plasma levels, lack of degradation by the gastrointestinal system, and lack of liver effects (first-pass drug metabolism) on drug molecules. Transdermal drug delivery offers a unique opportunity for non-invasive and controlled drug delivery, in contrast to needle-based and oral drug administration. Phonophoresis is a therapeutic method that may be helpful for the treatment of MTP.
There are potentially adverse treatment responses to ISTM that may occur. The patient may experience discomfort during the administration of the treatment, and petechiae (i.e., bruising) may become apparent during or after the treatment Although discomfort may be experienced, patients who have realized a decrease in symptoms have returned repeatedly for additional ISTM sessions other therapeutic modalities should be administered for pain management.
Clinical and scientific evidence supports that proper management of patients with headache should be multimodal including appropriate use of pharmacological and non-pharmacological.IASTM used to facilitate normal alignment of soft tissue and increase fibroblast recruitment and regeneration of damaged tissue. Phonophoresis is frequently used to treat pain associated with muscular disorders, enhancing skin absorption of the topical medication's molecules. Study report that lidocaine decreases sensory input from mrofascialTrps and release local Tenderness by lowering the degree of the reflex mechanism responsible for referred pain.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Dokki, Egypt, 12611
- Outpatient clinic - Faculty of Physical Therapy - Cairo University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Their age ranged from 30 to 40 years.
- BMI ranged from 18 to 25 kg /m2.
- TTH criteria according to the Headache Classification Committee of the International Headache Society has at least two of the following characteristics:
- Bilateral location.
- Pressing/tightening quality (non-pulsating).
- Mild or moderate intensity.
- Not aggravated by routine physical activity such as walking or climbing stairs.
- Patients have Trigger points in suboccipital muscle and trigger points 1 trapezius muscle.
- The presence of MTrPs will be determined using the diagnostic criteria described by Simons 1990, in which five major criteria and at least one of three minor criteria are needed for a clinical diagnosis of MPS.
Exclusion Criteria:
- Patients with a history of malignancy.
- Patients who had a history of cervical and cranial Surgery.
- Patients with major psychiatric disorders (major Depression).
- Patients with uncontrolled hypertension
- Patient with other causes of headache.
- Dysfunctions in the temporomandibular joint.
- Headaches associated with high fever, stiff neck, or rash, problems with vision, or profound dizziness.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Traditional Treatment Arm
conventional physical therapy program (infrared, stretching exercise, isometric strengthening exercise)
|
Infrared, Exercises, Stretching exercise of Suboccepital muscle
|
|
Experimental: IASTM treatment arm
Instrument-assisted soft tissue mobilization (IASTM) is a therapeutic technique that is based on the soft tissue mobilization rationale introduced by James Cyriax.
|
Infrared, Exercises, Stretching exercise of Suboccepital muscle
A lubricant (Vaseline) will be applied to the skin around the neck area prior to treatment and the M2t blade will be cleaned with an alcohol pad.
First, the M2T blade will used to find the exact areas of restriction in affected muscles.
Then the M2T blade will use at an angle of 45 to apply slow strokes along the muscle.
Changes in soft tissue consistency will detected by the clinician through vibrations of the instrument when it slides on areas of irregular fibrosis of the underneath connective tissue.
Once an adhesion is discovered, strokes are repeated for 5 min.
|
|
Experimental: Phonophoresis treatment arm
It will be consisted of 1 MHz pulsed mode with an intensity set at 1.5 W/cm2.
|
Infrared, Exercises, Stretching exercise of Suboccepital muscle
It will be consisted of 1 MHz pulsed mode with an intensity set at 1.5 W/cm2 and.
A 5 cm2 crystal head with an effective radiating area of 4.0 cm2 ±1.0 wills utilized for 5 Min for each trigger point of neck.
lidocine gelwill applied instead of coupling US gel used for transmission.
|
|
Experimental: Combined IASTM and phonophoresis treatment arm
Combined phonophoresis and M2t Blade
|
Infrared, Exercises, Stretching exercise of Suboccepital muscle
A lubricant (Vaseline) will be applied to the skin around the neck area prior to treatment and the M2t blade will be cleaned with an alcohol pad.
First, the M2T blade will used to find the exact areas of restriction in affected muscles.
Then the M2T blade will use at an angle of 45 to apply slow strokes along the muscle.
Changes in soft tissue consistency will detected by the clinician through vibrations of the instrument when it slides on areas of irregular fibrosis of the underneath connective tissue.
Once an adhesion is discovered, strokes are repeated for 5 min.
It will be consisted of 1 MHz pulsed mode with an intensity set at 1.5 W/cm2 and.
A 5 cm2 crystal head with an effective radiating area of 4.0 cm2 ±1.0 wills utilized for 5 Min for each trigger point of neck.
lidocine gelwill applied instead of coupling US gel used for transmission.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessing the change in pain intensity
Time Frame: Baseline and 4 weeks post-intervention
|
assessment via using visual analogue scale (VAS) most commonly consists of a 100mm horizontal line anchored with two opposite labels; patients mark a score on the scale using a vertical line.
A VAS is easy to use and therefore applicable to a variety of practice and research settings.
(0 means no pain & 10 means highest pain intensity).
|
Baseline and 4 weeks post-intervention
|
|
Assessing the change in neck disability
Time Frame: Baseline and 4 weeks post-intervention
|
assessment via using Neck disability index: The NDI can be scored as a raw score or doubled and expressed as a percent. Each section is scored on a 0 to 5 rating scale, in which zero means 'No pain' and 5 means 'Worst imaginable pain'. All the points can be summed to a total score. The test can be interpreted as a raw score, with a maximum score of 50, or as a percentage. 0 points or 0% means: no activity limitations, 50 points or 100% means complete activity limitation,Mean duration of the test: 3 to 7.8 minutes some benchmarks can be found in literature, Vernon and Moir presented the following interpretation: 0-4points (0-8%) no disability. 5-14points (10-28%) mild disability. 15-24points (30-48%) moderate disability. 25-34points (50-64%) severe disability. 35-50points (70-100%) complete disability. |
Baseline and 4 weeks post-intervention
|
|
Assessing the change in Pain Pressure Threshold
Time Frame: Baseline and 4 weeks post-intervention
|
assessment via using Pressure algometer: Pain Pressure Threshold (PPT) was measured by an algometer using a 1 cm2 disk surface area pressed vertically on MTrP.
To provoke pain, pressure was increased with a speed of 1kg/cm2/s-1
|
Baseline and 4 weeks post-intervention
|
|
Assessing the change in frequency of headache
Time Frame: Baseline and 4 weeks post-intervention
|
Headache frequency assessed after and before 12 sessions.
It was defined as the number of headache days per week.
The frequency of days with headache in the past weeks was registered by the participant
|
Baseline and 4 weeks post-intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Prof Abeer Yamany, Professor, Cairo university
- Study Director: Dr Mariam Omran, Lecturer, Cairo university
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Nada_MSc
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Headache
-
Canadian Memorial Chiropractic CollegeDr. Zaxx Co.UnknownMigraine Headache | Cervicogenic Headache | Tension-type HeadacheCanada
-
University GhentRecruitingTension-Type Headache | Cervicogenic Headache | Myofascial HeadacheBelgium
-
Danish Headache CenterEnrolling by invitationMigraine | Posttraumatic Headache | Tension HeadacheDenmark
-
Real Centro Universitario Maria CristinaRecruiting
-
Brooke Army Medical CenterThe University of Queensland; The Defense and Veterans Brain Injury CenterRecruitingHeadache, Migraine | Persistent Post Traumatic Headache | Cervicogenic HeadacheUnited States
-
Sunnybrook Health Sciences CentreNot yet recruitingPost Traumatic HeadacheCanada
-
University of WashingtonTerminatedChronic Post Traumatic HeadacheUnited States
-
Uniformed Services University of the Health SciencesNational Institutes of Health (NIH); University of North Carolina, Chapel Hill and other collaboratorsRecruitingPost-Traumatic Headache Chronic Without Intractable HeadacheUnited States
-
University of AlbertaCompletedChronic Headache | Chronic Daily Headache | Analgesic Rebound Headache | Headache, IntractableCanada
-
Foundation University IslamabadRecruiting
Clinical Trials on Conventional physical therapy program
-
Cairo UniversityCompleted
-
Ragaee Saeed MahmoudRecruiting
-
South Valley UniversityRecruiting
-
Ankara UniversityCompleted
-
Cairo UniversityRecruiting
-
Cairo UniversityCompleted
-
Kutahya Health Sciences UniversityCompletedKnee OsteoarthritisTurkey
-
Sword Health, SAEmory UniversityCompleted
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompleted